TILRAY
LIVE

Serial Number

97178343

Owner

TILRAY BRANDS, INC.

Attorney

Peter Sloane

Filing Date

Dec 17, 2021

Add to watchlist:

No watchlists yet
View on USPTO

TILRAY Trademark

Serial Number: 97178343

TILRAY is a trademark filed by TILRAY BRANDS, INC. on December 17, 2021. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 29 (Meats & Processed Foods), Class 31 (Natural Agricultural Products), Class 34 (Smokers Articles), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

TILRAY BRANDS, INC. (18 trademarks)

2701 EASTLAKE AVE E.
SEATTLE, WA 98102

Entity Type: 03

Tilray, Inc. (10 trademarks)

3rd Floor
Seattle, WA 98102

Entity Type: 03

Trademark Details

Filing Date

December 17, 2021

Registration Date

Not Registered

Goods & Services

Research services in the area of hemp and cannabis, hemp and cannabis related products, derivatives of hemp and cannabis, and natural health products containing hemp and cannabis, all of the foregoing involving only Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis

Providing the breeding, growing, cultivation, and harvesting of hemp and cannabis, all of the foregoing involving only Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; production of hemp and cannabis, namely, cultivation of hemp and cannabis plants, all of the foregoing involving only Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis

Dried cannabis, and dried hemp for smoking purposes; derivatives of hemp and cannabis, namely, resins and oils, for oral vaporizers for smoking; smokers' articles, namely, smoking pipes sold empty, pouches for use with hemp and cannabis, lighters for smokers, oral vaporizers for smokers sold empty, grinders for use with hemp and cannabis; all of the foregoing consisting solely of ingredients from Cannabis sativa L. with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD, and exclusively for use with goods having a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD

non-medicated, non-therapeutic and non-ingestible bath additives; non-medicated, non-therapeutic, non-ingestible bath herbs; non-ingestible bath oils; non-ingestible bath oils for cosmetic purposes; beauty care cosmetics; beauty creams for body care; beauty gels; beauty lotions; body and beauty care cosmetics; non-medicated, non-therapeutic body creams; non-medicated, non-therapeutic and non-ingestible body oils; cosmetic creams; non-ingestible cosmetic oils; cosmetics and make-up; non-medicated, non-therapeutic face and body lotions for cosmetic use; face and body milk for cosmetic use; face lotion for cosmetic use; hair care preparations; hair styling preparations; hand cream for cosmetic use; hand lotions for cosmetic use; non-medicated lip care preparations; lip conditioners; lip glosses; non-medicated liquid soaps; massage creams for non-medicated, non-therapeutic use; non-ingestible massage oils for non-medicated, non-therapeutic use; non-medicated, non-therapeutic bubble bath preparations; non-medicated preparations for the care of hair; non-medicated, non-therapeutic preparations for the care of skin; non-medicated preparations for the care of the scalp; non-medicated skin care preparations for cosmetic use; non-ingestible oils for non-medicated, non-therapeutic toiletry purposes; skin care preparations for cosmetic use; skin creams for cosmetic use; skin emollients for cosmetic use; skin lotions for cosmetic use; skin soap; soaps for body care; soaps for personal use; any hemp or cannabis ingredients in the foregoing derived solely from Cannabis sativa L. with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis

Retail store and wholesale distributorships in the field of, dried hemp and dried cannabis, and hemp and cannabis extracts, namely, hemp extracts and cannabis resins for smoking purposes, hemp and cannabis sterilized seeds, and hemp and cannabis plants, none of the foregoing goods consisting of, containing, or derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis; online retail store services featuring dried hemp and cannabis for smoking, for ingestion and for recreational consumption, none of the foregoing goods having a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis; online retail store services featuring hemp and cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; any ingredients from cannabis or hemp in the goods featured in the foregoing services are derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis, and none of the goods contain CBD; providing consumer information in the field of hemp and cannabis dispensary locations; providing ratings, reviews and recommendations on products and services for commercial purposes posted by users in the field of hemp and marijuana and cannabis via a website

Printed publications, namely, newsletters, brochures, reports and guides in the fields of hemp and cannabis

Hemp and cannabis related products, namely, oils, salves, concentrated pastes, tinctures, tablets and capsules, each containing hemp or cannabis for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils, salves, concentrated pastes, tinctures, tablets and capsules each containing resins and oils derived from hemp or cannabis for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing hemp or cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of hemp or cannabis, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated or therapeutic topical skin creams, bar and liquid soaps, bath additives, bath herbs, bath oils, body creams, body oils, face and body lotions, face and body milk, face lotion, and skin care preparations each containing derivatives of hemp or cannabis, for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; personal sexual lubricants; transdermal patches containing hemp or cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays containing hemp or cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; hemp and cannabis for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; hemp and cannabis related product, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and wellbeing, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from hemp or cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; all of the foregoing containing ingredients from hemp or cannabis derived solely from Cannabis sativa L. with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing any CBD

Live plants; Live hemp and cannabis plants; live hemp plants; hemp and cannabis seeds for agricultural purposes; all of the foregoing plants and seeds with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and none of the seeds being capable of germinating into a plant that contains more than 0.3 percent delta-9 THC on a dry weight basis

Providing entertainment information in the field of hemp and cannabis culture via a website; providing news via a website in the nature of current event reporting in the field of hemp and cannabis and cannabis culture; providing educational information in the field of hemp and cannabis-themed cultural events and festivals via a website

Edible oils and resins derived from hemp or cannabis, for use as comestibles; hemp and cannabis related products, namely, edible oils for use as comestibles; edible oils derived from hemp or cannabis for use as comestibles; food products containing hemp or cannabis, hemp or cannabis resins, and hemp or cannabis oils, namely, butter; all of the foregoing derived solely from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis and not containing any CBD

Filing History

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 14, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 14, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 14, 2026 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 24, 2025 RCCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 14, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 14, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 14, 2025 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 23, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
May 23, 2025 GNSL
SUSPENSION LETTER WRITTEN
May 23, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 22, 2025 TEME
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 22, 2025 CHAN
ASSIGNED TO LIE
May 20, 2025 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 6, 2025 ERSI
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 30, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 30, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 30, 2025 REAP
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 17, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 17, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 17, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 14, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 13, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 13, 2024 GNSL
SUSPENSION LETTER WRITTEN
Aug 13, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 12, 2024 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 11, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 11, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
May 11, 2024 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 6, 2024 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 6, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 6, 2023 GNSL
SUSPENSION LETTER WRITTEN
Nov 6, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 11, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 10, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 10, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 3, 2023 GNRN
NON-FINAL ACTION E-MAILED
Aug 3, 2023 GNRT
NON-FINAL ACTION WRITTEN
Aug 3, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 25, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 24, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 24, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 27, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 27, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 27, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 17, 2022 DOCK
ASSIGNED TO EXAMINER
Aug 1, 2022 DOCK
ASSIGNED TO EXAMINER
Aug 1, 2022 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 9, 2022 ASGN
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 22, 2021 NWOS
NEW APPLICATION ENTERED
Dec 21, 2021 NWAP